Skip to main content
NYXH
NASDAQ Industrial Applications And Services

Nyxoah Secures $15M EIB Loan, Major Shareholders Boost Stakes Post-$95M Offering

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$1.57
Mkt Cap
$156.884M
52W Low
$1.26
52W High
$8.588
52W Position info
25% above low
Off High info
82% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

NYXH sits 25% above its 52-week low of $1.26.

Summary

Nyxoah received $15 million in non-dilutive EIB funding, completing a $110 million capital raise, while key shareholders significantly increased their ownership stakes after the recent public offering.


Key Events · Financing and Capital Events · NYXH

  • Secured $15 Million Non-Dilutive EIB Loan

    Nyxoah received $15 million from the European Investment Bank, completing a $110 million aggregate financing package that includes the recent $95 million equity offering. This non-dilutive capital is earmarked for accelerating the U.S. commercial launch of Genio, R&D, and manufacturing scale-up.

  • Major Shareholder Robert Taub Increases Stake

    Robert Taub and his controlled entity, Robelga SRL, acquired voting securities, crossing the 10% ownership threshold to hold a combined 14.50% stake (14,490,277 voting rights) as of June 10, 2026, following the recent public offering.

  • Pierre-Edouard Stérin Boosts Ownership

    Pierre-Edouard Stérin, through his affiliates, acquired voting securities, crossing the 5% ownership threshold to hold a 7.23% stake (7,221,666 voting rights) as of June 10, 2026, indicating increased confidence post-offering.

  • Shareholders' Meeting to Renew Authorized Capital

    An extraordinary shareholders' meeting is scheduled for July 9, 2026, to vote on renewing the board's authorization to increase share capital up to the current capital amount for five years, providing future financing flexibility.


Analysis · NYXH · Industrial Applications And Services

This filing confirms Nyxoah's receipt of a crucial $15 million non-dilutive loan from the European Investment Bank, completing a $110 million financing package that significantly strengthens its balance sheet and addresses prior "going concern" doubts. Concurrently, major shareholders Robert Taub and Pierre-Edouard Stérin substantially increased their stakes following the recent $95 million public offering, demonstrating strong confidence in the company's future after the capital raise.

At the time of this filing, NYXH was trading at $1.57 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $156.9M. The 52-week trading range was $1.26 to $8.59. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NYXH - Latest Insights

NYXH
Jul 09, 2026, 4:30 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $1.67
Real-time Price: $1.48 info
Change: -$0.194 (-12%) info
Market Cap: $147.107M info
NYXH
Jun 15, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.55
Real-time Price: $1.48 info
Change: -$0.074 (-5%) info
Market Cap: $147.107M info
NYXH
Jun 11, 2026, 5:00 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $1.48
Real-time Price: $1.48 info
Change: -$0.0040 (-0.27%) info
Market Cap: $147.107M info
NYXH
Jun 10, 2026, 4:30 PM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $1.30
Real-time Price: $1.48 info
Change: +$0.176 (+14%) info
Market Cap: $147.107M info
NYXH
Jun 10, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.31
Real-time Price: $1.48 info
Change: +$0.166 (+13%) info
Market Cap: $147.107M info